ArticleIndian journal of psychiatry2026
Micro-RNA signature in alcohol dependence: Circulating miRNA-92b and miRNA-382-5p levels as candidate biomarkers: A case-control study.
Article in Indian journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alcohol dependence syndrome (ADS) involves compulsive alcohol use despite negative consequences. Early identification significantly improves outcomes. MicroRNAs (miRNAs) that regulate gene expression, show promise as potential biomarkers for this condition through distinctive molecular signatures. Aim: To determine expression of miRNA-92b and miRNA 382-5p in serum of drug naïve patients of ADS in comparison to matched healthy controls to investigate the potential of miRNA 92b and miRNA 382-5p as diagnostic biomarkers for ADS. Methods: A case-control study examined miRNA expression patterns between ADS patients and matched healthy subjects. Statistical methods were applied to evaluate the resulting data. Through receiver operating characteristic (ROC) curve analysis, optimal threshold values were determined for the two miRNAs under investigation. Results: Findings revealed median expression levels of miRNA-382-5p: 0.001 (Q1: 0.000, Q3: 0.005) in cases and 0.008 (Q1: 0.005, Q3: 0.021) in controls. Median expression levels of miRNA 92b: 0.00 (Q1: 0.00, Q3: 0.01) in cases and 3.68 (Q1: 1.16, Q3: 6.34) in controls. Both being statistically significant. ROC for miRNA-382-5p showed area under the curve (AUC) as 0.86 and for miRNA 92b as 0.99. These results indicate that serum levels of miRNA-92b and miRNA 382-5p, can be used as potential biomarkers for the detection and diagnosis of ADS. Conclusion: The association between serum miRNA-92b and miRNA-382 with alcohol use offers a promising avenue for research in alcohol use disorders (AUD). The current findings highlight their potential as biomarkers, with a high statistical significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.